|
1
|
Mendoza-Muñoz N, Leyva-Gómez G, Piñón-Segundo E, Zambrano-Zaragoza ML, Quintanar-Guerrero D, Del Prado Audelo ML, Urbán-Morlán Z. Trends in biopolymer science applied to cosmetics. Int J Cosmet Sci 2023; 45:699-724. [PMID: 37402111 DOI: 10.1111/ics.12880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2022] [Revised: 05/02/2023] [Accepted: 06/22/2023] [Indexed: 07/05/2023]
Abstract
The term biopolymer refers to materials obtained by chemically modifying natural biological substances or producing them through biotechnological processes. They are biodegradable, biocompatible and non-toxic. Due to these advantages, biopolymers have wide applications in conventional cosmetics and new trends and have emerged as essential ingredients that function as rheological modifiers, emulsifiers, film-formers, moisturizers, hydrators, antimicrobials and, more recently, materials with metabolic activity on skin. Developing approaches that exploit these features is a challenge for formulating skin, hair and oral care products and dermatological formulations. This article presents an overview of the use of the principal biopolymers used in cosmetic formulations and describes their sources, recently derived structures, novel applications and safety aspects of the use of these molecules.
Collapse
Affiliation(s)
- Néstor Mendoza-Muñoz
- Laboratorio de Farmacia, Facultad de Ciencias Químicas, Universidad de Colima, Colima, Mexico
| | - Gerardo Leyva-Gómez
- Departamento de Farmacia, Facultad de Química, Ciudad Universitaria, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
| | - Elizabeth Piñón-Segundo
- Laboratorio de Sistemas Farmacéuticos de Liberación Modificada, L13, Unidad de Investigación Multidisciplinaria, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Mexico
| | - María L Zambrano-Zaragoza
- Laboratorio de Procesos de Transformación y Tecnologías Emergentes de Alimentos, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Cuautitlán Izcalli, Mexico
| | - David Quintanar-Guerrero
- Laboratorio de Posgrado en Tecnología Farmacéutica, Universidad Nacional Autónoma de México, FES-Cuautitlán, Cuautitlán Izcalli, Mexico
| | | | - Zaida Urbán-Morlán
- Centro de Información de Medicamentos, Facultad de Química, Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico
| |
Collapse
|
|
2
|
Rivas F, Erxleben D, Smith I, Rahbar E, DeAngelis PL, Cowman MK, Hall AR. Methods for isolating and analyzing physiological hyaluronan: a review. Am J Physiol Cell Physiol 2022; 322:C674-C687. [PMID: 35196167 PMCID: PMC8977137 DOI: 10.1152/ajpcell.00019.2022] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2022] [Revised: 02/22/2022] [Accepted: 02/22/2022] [Indexed: 01/01/2023]
Abstract
The carbohydrate hyaluronan (or hyaluronic acid, HA) is found in all human tissues and biofluids where it has wide-ranging functions in health and disease that are dictated by both its abundance and size. Consequently, hyaluronan evaluation in physiological samples has significant translational potential. Although the analytical tools and techniques for probing other biomolecules such as proteins and nucleic acids have become standard approaches in biochemistry, those available for investigating hyaluronan are less well established. In this review, we survey methods related to the assessment of native hyaluronan in biological specimens, including protocols for separating it from biological matrices and technologies for determining its concentration and molecular weight.
Collapse
Affiliation(s)
- Felipe Rivas
- Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina
| | - Dorothea Erxleben
- Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina
| | - Ian Smith
- Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina
| | - Elaheh Rahbar
- Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina
| | - Paul L DeAngelis
- Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
| | - Mary K Cowman
- Department of Biomedical Engineering, New York University Tandon School of Engineering, New York, New York
- Department of Orthopedic Surgery, New York University Grossman School of Medicine, New York, New York
| | - Adam R Hall
- Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina
- Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina
| |
Collapse
|
|
3
|
Ruggeri M, Pavan M, Soato M, Panfilo S, Barbera C, Galesso D, Miele D, Rossi S, Di Lucia A, Ferrari F, Sandri G. Synergy of Hydeal-D ® and Hyaluronic Acid for Protecting and Restoring Urothelium: In Vitro Characterization. Pharmaceutics 2021; 13:1450. [PMID: 34575526 PMCID: PMC8465558 DOI: 10.3390/pharmaceutics13091450] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 09/06/2021] [Accepted: 09/08/2021] [Indexed: 11/29/2022] Open
Abstract
Interstitial cystitis (IC) or painful bladder syndrome is a chronic dysfunction due to an inflammatory condition, characterized by bladder pain and urinary frequency. Currently, no gold standard therapy is available since IC does not respond to conventional ones. Given these premises, the aim of this work was the in vitro characterization of biological properties (mucoadhesion and anti-inflammatory activity) of a commercial product (HydealCyst-HydC) based on hyaluronic acid (HA) and the benzyl ester of HA (Hydeal-D®) intended for bladder instillation to restore and/or protect the urothelial layer of glycosamino glycans (GAGs). The in vitro characterization demonstrated that an interaction product is formed between HA and Hydeal-D® that has a role in the rheological behavior and mucoadhesive properties. HA was identified as a key component to form the mucoadhesive joint, while the interaction of HA with Hydeal-D® improved polysaccharide stability and prolonged the activity ex vivo. Moreover, HydC is cytocompatible with urothelial cells (HTB-4) and possesses an anti-inflammatory effect towards these cells by decreasing the secretion of IL-6 and IL-8, which were both increased in patients with IC, and by increasing the secretion of sulfated GAGs. These two findings, along with the resilience properties of the formulation due to mucoadhesion, suggest the active role of HydC in protecting and restoring urothelium homeostasis.
Collapse
Affiliation(s)
- Marco Ruggeri
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy; (M.R.); (D.M.); (S.R.); (F.F.)
| | - Mauro Pavan
- Fidia Farmaceutici S.p.A., Via Ponte Della Fabbrica 3/A, 35031 Abano Terme, Italy; (M.P.); (M.S.); (S.P.); (C.B.); (D.G.)
| | - Matteo Soato
- Fidia Farmaceutici S.p.A., Via Ponte Della Fabbrica 3/A, 35031 Abano Terme, Italy; (M.P.); (M.S.); (S.P.); (C.B.); (D.G.)
| | - Susi Panfilo
- Fidia Farmaceutici S.p.A., Via Ponte Della Fabbrica 3/A, 35031 Abano Terme, Italy; (M.P.); (M.S.); (S.P.); (C.B.); (D.G.)
| | - Carlo Barbera
- Fidia Farmaceutici S.p.A., Via Ponte Della Fabbrica 3/A, 35031 Abano Terme, Italy; (M.P.); (M.S.); (S.P.); (C.B.); (D.G.)
| | - Devis Galesso
- Fidia Farmaceutici S.p.A., Via Ponte Della Fabbrica 3/A, 35031 Abano Terme, Italy; (M.P.); (M.S.); (S.P.); (C.B.); (D.G.)
| | - Dalila Miele
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy; (M.R.); (D.M.); (S.R.); (F.F.)
| | - Silvia Rossi
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy; (M.R.); (D.M.); (S.R.); (F.F.)
| | - Alba Di Lucia
- Fidia Farmaceutici S.p.A., Via Ponte Della Fabbrica 3/A, 35031 Abano Terme, Italy; (M.P.); (M.S.); (S.P.); (C.B.); (D.G.)
| | - Franca Ferrari
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy; (M.R.); (D.M.); (S.R.); (F.F.)
| | - Giuseppina Sandri
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy; (M.R.); (D.M.); (S.R.); (F.F.)
| |
Collapse
|